ASSEMBLY APPROPRIATIONS COMMITTEE

STATEMENT TO

[First Reprint]

SENATE, No. 3278

STATE OF NEW JERSEY

DATED:  DECEMBER 18, 2025

      The Assembly Appropriations Committee reports favorably Senate Bill No. 3278 (1R).

      As reported, this bill extends permission to emergency medical technicians (EMTs) to administer glucagon and blood glucose tests.  The commissioner may by regulation or order modify, suspend, or terminate the certification of an emergency medical technician to administer glucagon and blood glucose tests, if necessary for public health, safety, or welfare.

      Glucagon is a hormone that the human body produces to prevent low blood sugar.  In people with diabetes, this natural production is not enough during severe hypoglycemia.  Emergency glucagon is a medication used when a person with diabetes is experiencing severe hypoglycemia, or low blood sugar, and cannot take sugar orally.  Once injected, glucagon raises the blood sugar.  Glucagon comes in several forms including a nasal spray, auto-injectors, prefilled syringes, or a powder that must be mixed with a liquid before injecting. 

      As reported by the committee, Senate Bill No. 3278 (1R) is identical to the Assembly Committee Substitute for Assembly Bill No. 4280, which was also reported by the committee on this date.

FISCAL IMPACT:

      This bill is not certified as requiring a fiscal note.